A Phase 2 Study Evaluating Efficacy, Safety and Tolerability of Different Doses and Regimens of Allocetra-OTS for the Treatment of Organ Failure in Adult Sepsis Patients

NCT04612413 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

148

Enrollment

INDUSTRY

Sponsor class

Conditions

Sepsis
Community-acquired Pneumonia
Urinary Tract Infections
Cholecystitis, Acute
Cholangitis Acute
Intraabdominal Infections

Interventions

DRUG: Allocetra-OTS
OTHER: Placebo

Sponsor

Enlivex Therapeutics Ltd.